Every 13F-reported equity position this quarter with its quarter-over-quarter change; each row traces to the filer's 13F-HR on EDGAR.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR
Every 13F-reported equity position this quarter with its quarter-over-quarter change; each row traces to the filer's 13F-HR on EDGAR.
TRV GP IV, LLC (CIK 1688325) reported $253.7M across 2 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: MAZE ($133.5M, 52.63%), TNGX ($120.2M, 47.37%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | MAZE | MAZE THERAPEUTICS, INC. | $133.5M | 52.63% | 4.5M | Hold |
| 2 | TNGX | TANGO THERAPEUTICS, INC. | $120.2M | 47.37% | 6.4M | Hold |
Source: SEC Form 13F filings · as of 2026-06-30